Infectious Diseases Newsletter

A team of researchers across Yale School of Medicine and the University of Texas Health Science Center at San Antonio has published a set of papers on innovations in patient care for those diagnosed with hepatitis C who also are living with HIV.

Lenacapavir is a new FDA-approved HIV injection that is safe, highly effective, and taken only twice per year. Its approval was based on work led by Onyema Ogbuagu, MD.

A new study by Yale School of Medicine (YSM) and NYU Grossman School of Medicine researchers demonstrates the validity of two new diagnostic tools—the Rapid Opioid Use Disorder Assessment and the Rapid Stimulant Use Disorder Assessment. These instruments may be used to increase diagnoses of opioid and stimulant use disorder and access to treatment.

Many Ukrainian refugees fleeing the war have encountered obstacles when seeking therapies for opioid use disorder in European Union countries, a new Yale-led study finds. The study examines the barriers to opioid agonist therapies (OAT) and providers’ responses to increased demand in OAT enrollment.

Meet Ishani Batuwantudave, portfolio and grant accountant, who manages portfolios for a team of principal investigators within the Section of Infectious Diseases.

In 2016, Zika virus gained international attention after Brazilian children were born with congenital deformities and neurological disorders secondary to contracting the Zika virus in utero. But the disease is not new; Zika was discovered in the 1940s in Uganda. We asked Dr. Maudry Laurent-Rolle some common questions about Zika, a positive-strand RNA flavivirus that replicates quickly within an infected individual.

Cordyceps, or Ophiocordyceps unilateralis, is a real fungus that parasitizes the brains of insects like ants or spiders. Fortunately for humankind, while mind-controlling fungal infections make for great television, a Yale expert says there is no need to begin doomsday prepping.

A team of Yale and Cameroonian researchers has created a checklist for global health scholars to ensure fairness during the entire research process, from study design and funding through data collection, writing, and publication.

As part of our “Meet Yale Internal Medicine” series, we are featuring Benjamin Goldman-Israelow, MD, PhD, assistant professor in medicine and former ABIM Physician-Scientist Research Pathway Resident.